Immunotherapy: new options in breast cancer treatment-Reference-Cited by-同舟云学术

Immunotherapy: new options in breast cancer treatment

Published:2003-06 Issue:3 Volume:3 Page:403-408
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Untch Michael,Ditsch Nina,Hermelink Kerstin

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.3.3.403

Reference6 articles.

1. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

2. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

3. Konecny G, Untch M, Crohns C et al. c-erbB-2: Uberexpression und herceptin® in der therapie des marnmakarzinoms. In: Diagnostik und Therapie des Mammakarzinonzs.W Zuckschwer, Munchen, Germany (2000).

4. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Immunotherapy Treatments of Primary Breast Cancer Subtypes;Biomedicines;2024-04-18

2. Mass Spectrometric ITEM-ONE and ITEM-TWO Analyses Confirm and Refine an Assembled Epitope of an Anti-Pertuzumab Affimer;Biomolecules;2023-12-24

3. Current Molecular Combination Therapies Used for the Treatment of Breast Cancer;International Journal of Molecular Sciences;2022-09-20

4. Towards Breast Cancer Vaccines, Progress and Challenges;Current Drug Discovery Technologies;2019-10-14

5. The Role of Selvester Score on 12-Lead ECG in Determination of Left Ventricular Systolic Dysfunction Among Patients Receiving Trastuzumab Therapy;European Journal of Therapeutics;2019-03-14